comprehensive -WSS

comprehensive

author：explore 2025-09-29 22:36:58 - browse：27

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Jerome Adams on the need for new antivirals for Covid

WSS

Continuity nursing helped my family in our darkest PICU moments

Novavax promises a turnaround & Lilly roils the obesity market

How one medical school became remarkably diverse

FDA approves Sage Therapeutics’ rapid

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Malaria cases in Florida and Texas: Here’s what you need to know

leisure time

comprehensive

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CDC recommends RSV monoclonal antibody for infants

Duchenne breakthrough therapy leaves behind pioneering families

Alnylam reports growth in sales of rare disease treatments

Peter Hotez and the public health issue of online harassment

FDA scientists endorse Pfizer/BioNTech Covid

Jerome Adams on the need for new antivirals for Covid

The cancer stories no one wants to hear

Dobbs anniversary: the lost opportunity of abortion as health care

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

leisure time

Medical records are filled with copy

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Pharma showers House GOP doctor with campaign cash

'Null' research findings aren't empty of meaning. Let's publish them

Malaria cases in Florida and Texas: Here’s what you need to know

The cancer stories no one wants to hear

knowledge

hotspot

focus

hotspot